SCHEMBL14928601

SCHEMBL14928601

CCCOc1ncc(N)cc1C1CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPC6 Q9Y210 3/20 0.36
KDM4E B2RXH2 2/20 0.35
MEN1 O00255 1/20 0.35
USP2 O75604 1/20 0.35
ALDH1A1 P00352 1/20 0.35
TP53 P04637 1/20 0.35
POLB P06746 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
CASP1 P29466 1/20 0.35
HTT P42858 1/20 0.35
CASP7 P55210 1/20 0.35
KMT2A Q03164 1/20 0.35
ATM Q13315 1/20 0.35
CDK1 P06493 1/20 0.33
CCNB1 P14635 1/20 0.33
CCNA2 P20248 1/20 0.33
CDK2 P24941 1/20 0.33
CCNA1 P78396 1/20 0.33
SCN9A Q15858 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14923457 0.87 SCN9A (0.34) TRPC6KDM4ETP53GAAMAPT
SCHEMBL3379187 0.86 CNR2 (0.38) SCN9ASCN5ASSTR4CNR2
SCHEMBL3368287 0.80 MAPT (0.37) MAPTCASP1
SCHEMBL14928368 0.76 MAPT (0.39) MEN1ALDH1A1MAPTKMT2ANPC1
SCHEMBL14928306 0.75 KDM4E (0.40) KDM4EMEN1USP2ALDH1A1TP53
SCHEMBL3375412 0.73 CSNK2A1 (0.39) KDM4EMEN1USP2ALDH1A1TP53
SCHEMBL14928594 0.73 ALDH1A1 (0.39) KDM4EMEN1USP2ALDH1A1TP53
SCHEMBL14761797 0.72 ALDH1A1 (0.39) KDM4EMEN1USP2ALDH1A1MAPT
SCHEMBL22165236 0.71 ABL1 (0.34)
SCHEMBL14761755 0.71 CNR2 (0.38) ALDH1A1MAPTCNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, CD38, BTK TRPC6 157/4885KDM4E 2420/4885MEN1 2870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.